As of 2025-12-31, the Relative Valuation of Revance Therapeutics Inc (RVNC) is (32.95) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.65 USD, the upside of Revance Therapeutics Inc based on Relative Valuation is -1002.8%.
The range of the Relative Valuation is (32.58) - (34.45) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.3x - 19.5x | 18.3x |
| Forward P/E multiples | 18.4x - 21.0x | 19.0x |
| Fair Price | (32.58) - (34.45) | (32.95) |
| Upside | -992.6% - -1043.9% | -1002.8% |
| Date | P/E |